Model-based meta-analysis of HbA1c reduction across SGLT2 inhibitors using dose adjusted by urinary glucose excretion
Sign Up to like & getrecommendations! Published in 2024 at "Scientific Reports"
DOI: 10.1038/s41598-024-76256-6
Abstract: This study was aimed to evaluate whether the dose–response relationship of the sodium glucose co-transporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM)—canagliflozin, dapagliflozin, empagliflozin, ipragliflozin, luseogliflozin, and tofogliflozin—can be explained in a… read more here.
Keywords: hba1c; urinary glucose; glucose excretion; hba1c reduction ... See more keywords
Is insulin the preferred treatment for HbA1c >9%?
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Diabetes"
DOI: 10.1111/1753-0407.12575
Abstract: The algorithms and guidelines of the American Association of Clinical Endocrinologists and the American Diabetes Association recommend that insulin administration be strongly considered for people with type 2 diabetes (T2D) with HbA1c levels exceeding 9.0%… read more here.
Keywords: reduction; insulin; baseline hba1c; hba1c ... See more keywords